Analyst Davide Longo from TP ICAP MIDCAP reiterated a Buy rating on Maps S.p.A. (MAPS – Research Report) and keeping the price target at €5.40.
Davide Longo has given his Buy rating due to a combination of factors that highlight Maps S.p.A.’s strategic positioning and growth potential. The recent award of a public tender to Maps S.p.A., through its subsidiary Artexe S.p.A., in collaboration with Telecom Italia, is a significant milestone. This contract, valued at €1.5 million, not only enhances revenue visibility for 2025 and beyond but also underscores Maps’ capability to secure strategic partnerships and tenders.
Furthermore, the contract includes options for renewal and regional expansion, which could potentially add over €2.6 million in revenue. This development supports Maps’ organic growth and bolsters its credibility in the Italian public healthcare sector. The integrated physical-digital offering of Maps S.p.A. is well-positioned in the expanding Patient Experience market, further justifying the Buy recommendation with a target price of €5.4 per share.
MAPS’s price has also changed moderately for the past six months – from EUR2.720 to EUR3.540, which is a 30.15% increase.